Usability and effectiveness of Suprathel® in partial thickness burns in children

Z M Rashaan, P Krijnen, J H Allema, A F Vloemans, I B Schipper, R S Breederveld, Z M Rashaan, P Krijnen, J H Allema, A F Vloemans, I B Schipper, R S Breederveld

Abstract

Purpose: Evaluation of usability and effectiveness of Suprathel® in the treatment of partial thickness burns in children.

Methods: A prospective, observational study to evaluate adherence of Suprathel® to the wound bed, reepithelialization time, grafting, wound colonization and infection, pain, dressing changes, length of hospital stay (LOS) and scar formation.

Results: Twenty-one children (median age 2.4 years, range 5 months-14 years) with a median total body surface area (TBSA) of 4 % (range 1-18) were included. Median LOS was 10 days (range 3-20). Median outer layer dressing changes was 3 (range 1-14). Suprathel® was only adherent in wounds debrided with Versajet®. Median reepithelialization time was 13 days (range 7-29). Three patients needed a split skin graft. There were 7 (33 %) patients with wound colonization before application of Suprathel®. This increased to 12 (57 %) patients during treatment. One patient developed a wound infection. Median visual analog scale (VAS) scores for background and procedural pain in patients >7 years were 3.2 (range 2-5) and 3.5 (range 2-5), respectively. In younger patients, median background and procedural COMFORT-B scores were 13.8 (range 10-23) and 14.8 (range 13-23, p = 0.03), respectively. Patient and Observer Scar Assessment Scale (POSAS) scores were favorable after 3 and 6 months post burn.

Conclusions: Suprathel® provides potential advantages regarding pain and scar formation, but extensive wound debridement is needed to achieve adequate adherence.

Keywords: Children; Effectiveness; Partial thickness burns; Suprathel®; Usability.

Conflict of interest statement

Funding

This project was funded by Dutch Burns Foundation (WO/12.109) and initiated by the Leiden Medical University Center (LUMC).

Ethical approval

The local ethics committees approved our study (Reference No.: 2012–346). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Parents of the included pediatric patients gave informed consent prior to the inclusion in the study.

Conflict of interest

Z. M. Rashaan, P. Krijnen, J. H. Allema, A. F. P. Vloemans, I. B. Schipper and R. S. Breederveld declare that they have no conflict of interest.

References

    1. Vloemans AF, Hermans MH, van der Wal MB, Liebregts J, Middelkoop E. Optimal treatment of partial thickness burns in children: a systematic review. Burns. 2014;40(2):177–190. doi: 10.1016/j.burns.2013.09.016.
    1. Vloemans AF, Dokter J, van Baar ME, Nijhuis I, Beerthuizen GI, Nieuwenhuis MK, et al. Epidemiology of children admitted to the Dutch burn centres changes in referral influence admittance rates in burn centres. Burns. 2011;37(7):1161–1167. doi: 10.1016/j.burns.2011.05.001.
    1. Birchenough SA, Gampper TJ, Morgan RF. Special considerations in the management of pediatric upper extremity and hand burns. J Craniofac Surg. 2008;19(4):933–941. doi: 10.1097/SCS.0b013e318175f3f6.
    1. Kim LK, Martin HC, Holland AJ. Medical management of paediatric burn injuries: best practice. J Paediatr Child Health. 2012;48(4):290–295. doi: 10.1111/j.1440-1754.2011.02128.x.
    1. Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK. Suprathel—an innovative, resorbable skin substitute for the treatment of burn victims. Burns. 2007;33(2):221–229. doi: 10.1016/j.burns.2006.04.024.
    1. Highton L, Wallace C, Shah M. Use of Suprathel® for partial thickness burns in children. Burns. 2013;39(1):136–141. doi: 10.1016/j.burns.2012.05.005.
    1. Schwarze H, Kuntscher M, Uhlig C, Hierlemann H, Prantl L, Noack N, et al. Suprathel, a new skin substitute, in the management of donor sites of split-thickness skin grafts: results of a clinical study. Burns. 2007;33(7):850–854. doi: 10.1016/j.burns.2006.10.393.
    1. Keck M, Selig HF, Lumenta DB, Kamolz LP, Mittlbock M, Frey M. The use of Suprathel((R)) in deep dermal burns: first results of a prospective study. Burns. 2012;38(3):388–395. doi: 10.1016/j.burns.2011.09.026.
    1. Everett M, Massand S, Davis W, Burkey B, Glat PM. Use of a copolymer dressing on superficial and partial-thickness burns in a paediatric population. J Wound Care. 2015;24(7):S4–S8. doi: 10.12968/jowc.2015.24.Sup7.S4.
    1. Kimble RM, Mott J, Joethy J. Versajet hydrosurgery system for the debridement of paediatric burns. Burns. 2008;34(2):297–298. doi: 10.1016/j.burns.2007.08.018.
    1. Gauglitz GG, Shahrokhi S. Clinical manifestations, diagnosis, and treatment of burn wound sepsis. 2014.
    1. Greenhalgh DG, Saffle JR, Holmes JH, Gamelli RL, Palmieri TL, Horton JW, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776–790. doi: 10.1097/BCR.0b013e3181599bc9.
    1. Rice P, Orgil P. Classification of burns. 2014.
    1. van Dijk M, Peters JW, van Deventer P, Tibboel D. The COMFORT Behavior Scale: a tool for assessing pain and sedation in infants. Am J Nurs. 2005;105(1):33–36. doi: 10.1097/00000446-200501000-00019.
    1. van der Wal MB, Verhaegen PD, Middelkoop E, van Zuijlen PP. A clinimetric overview of scar assessment scales. J Burn Care Res. 2012;33(2):e79–e87. doi: 10.1097/BCR.0b013e318239f5dd.
    1. van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg. 2005;116(2):514–522. doi: 10.1097/01.prs.0000172982.43599.d6.
    1. Rashaan ZM, Krijnen P, Klamer RR, Schipper IB, Dekkers OM, Breederveld RS. Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis. Wound Repair Regen. 2014;22(4):473–482. doi: 10.1111/wrr.12196.
    1. Rahmanian-Schwarz A, Beiderwieden A, Willkomm LM, Amr A, Schaller HE, Lotter O. A clinical evaluation of Biobrane® and Suprathel® in acute burns and reconstructive surgery. Burns. 2011;37(8):1343–1348. doi: 10.1016/j.burns.2011.07.010.
    1. Schwarze H, Kuntscher M, Uhlig C, Hierlemann H, Prantl L, Ottomann C, et al. Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study. Ann Plast Surg. 2008;60(2):181–185. doi: 10.1097/SAP.0b013e318056bbf6.
    1. Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns. 2006;32(8):992–999. doi: 10.1016/j.burns.2006.02.007.
    1. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma. 1983;23(10):895–898. doi: 10.1097/00005373-198310000-00009.
    1. Barret JP, Dziewulski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane versus 1 % silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg. 2000;105(1):62–65. doi: 10.1097/00006534-200001000-00010.
    1. Bugmann P, Taylor S, Gyger D, Lironi A, Genin B, Vunda A, et al. A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns. 1998;24(7):609–612. doi: 10.1016/S0305-4179(98)00095-3.
    1. Kumar RJ, Kimble RM, Boots R, Pegg SP. Treatment of partial-thickness burns: a prospective, randomized trial using transcyte. ANZJ Surg. 2004;74(8):622–626. doi: 10.1111/j.1445-1433.2004.03106.x.
    1. Lal S, Barrow RE, Wolf SE, Chinkes DL, Hart DW, Heggers JP, et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock. 2000;14(3):314–318. doi: 10.1097/00024382-200014030-00013.
    1. Neale HW, Billmire DA, Carey JP. Reconstruction following head and neck burns. Clin Plast Surg. 1986;13(1):119–136.
    1. Cubison TCS, Harley O, Gilbert PM, editors. Paediatric scalds: an audit of current practice and presentation of suggested guidelines for follow up of scalds over 5 % TBSA. British Burn Association Meeting; 2003.
    1. Ryssel H, Germann G, Riedel K, Reichenberger M, Hellmich S, Kloeters O. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study. Ann Plast Surg. 2010;65(4):391–395. doi: 10.1097/SAP.0b013e3181d6e2f2.
    1. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14(2):244–269. doi: 10.1128/CMR.14.2.244-269.2001.
    1. Heggers JP, Robson MC, Doran ET. Quantitative assessment of bacterial contamination of open wounds by a slide techniue. Trans R Soc Trop Med Hyg. 1969;63(4):532–534. doi: 10.1016/0035-9203(69)90043-1.
    1. Heggers JP. Defining infection in chronic wounds: does it matter? J Wound Care. 1998;7(8):389–392. doi: 10.12968/jowc.1998.7.8.389.
    1. Raahave D, Friis-Moller A, Bjerre-Jepsen K, Thiis-Knudsen J, Rasmussen LB. The infective dose of aerobic and anaerobic bacteria in postoperative wound sepsis. Arch Surg. 1986;121(8):924–929. doi: 10.1001/archsurg.1986.01400080070012.
    1. Brook I, Finegold SM. Aerobic and anaerobic bacteriology of cutaneous abscesses in children. Pediatrics. 1981;67(6):891–895.
    1. Eriksson G, Eklund AE, Kallings LO. The clinical significance of bacterial growth in venous leg ulcers. Scand J Infect Dis. 1984;16(2):175–180. doi: 10.3109/00365548409087138.
    1. Hansson C, Hoborn J, Moller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol. 1995;75(1):24–30.
    1. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17(2):91–96. doi: 10.1097/00001432-200404000-00004.
    1. Singer AJ, McClain SA. Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair Regen. 2002;10(6):372–377. doi: 10.1046/j.1524-475X.2002.10606.x.
    1. Latarjet J, Choinere M. Pain in burn patients. Burns. 1995;21(5):344–348. doi: 10.1016/0305-4179(95)00003-8.
    1. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD. Burn injury pain: the continuing challenge. J Pain. 2007;8(7):533–548. doi: 10.1016/j.jpain.2007.02.426.
    1. McGrath PJ, Vair C. Psychological aspects of pain management of the burned child. Child Health Care. 1984;13(1):15–19. doi: 10.1207/s15326888chc1301_3.
    1. Thurber CA, Martin-Herz SP, Patterson DR. Psychological principles of burn wound pain in children. I: theoretical framework. J Burn Care Rehabil. 2000;21(4):376–387. doi: 10.1097/00004630-200021040-00019.
    1. Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adoles cMed. 1998;152(2):147–149.
    1. Kaartinen IS, Kuokkanen HO. Suprathel® causes less bleeding and scarring than Mepilex® Transfer in the treatment of donor sites of split-thickness skin grafts. J Plast Surg Hand Surg. 2011;45(4–5):200–203. doi: 10.3109/2000656X.2011.583515.
    1. Mostaque AK, Rahman KB. Comparisons of the effects of biological membrane (amnion) and silver sulfadiazine in the management of burn wounds in children. J Burn Care Res. 2011;32(2):200–209. doi: 10.1097/BCR.0b013e31820aad94.
    1. Wood F, Martin L, Lewis D, Rawlins J, McWilliams T, Burrows S, et al. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane® synthetic wound dressing, with or without autologous cell suspension, to the local standard treatment regimen in paediatric scald injuries. Burns. 2012;38(6):830–839. doi: 10.1016/j.burns.2011.12.020.
    1. Pape SA, Skouras CA, Byrne PO. An audit of the use of laser Doppler imaging (LDI) in the assessment of burns of intermediate depth. Burns. 2001;27(3):233–239. doi: 10.1016/S0305-4179(00)00118-2.

Source: PubMed

3
Abonnere